Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
869
-
Total 13F shares, excl. options
-
357M
-
Shares change
-
+327K
-
Total reported value, excl. options
-
$41.5B
-
Value change
-
+$42.8M
-
Put/Call ratio
-
1.03
-
Number of buys
-
398
-
Number of sells
-
-414
-
Price
-
$116.18
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q1 2023
1,025 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q1 2023.
DEXCOM INC - Common Stock (DXCM) has 869 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 357M shares
of 392M outstanding shares and own 91.17% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (44.1M shares), BlackRock Inc. (33.3M shares), BAILLIE GIFFORD & CO (17.2M shares), STATE STREET CORP (16.1M shares), SANDS CAPITAL MANAGEMENT, LLC (13.7M shares), FMR LLC (10.8M shares), Capital Research Global Investors (9.27M shares), GEODE CAPITAL MANAGEMENT, LLC (8.28M shares), Nuveen Asset Management, LLC (7.86M shares), and JENNISON ASSOCIATES LLC (7.26M shares).
This table shows the top 869 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.